Efficacy of convalescent plasma for treatment of COVID-19 in Uganda

RATIONALE: Convalescent plasma (CCP) has been studied as a potential therapy for COVID-19, but data on its efficacy in Africa are limited. OBJECTIVE: In this trial we set out to determine the efficacy of CCP for treatment of COVID-19 in Uganda. MEASUREMENTS: Patients with a positive SARS-CoV-2 rever...

Descripción completa

Detalles Bibliográficos
Autores principales: Kirenga, Bruce, Byakika-Kibwika, Pauline, Muttamba, Winters, Kayongo, Alex, Loryndah, Namakula Olive, Mugenyi, Levicatus, Kiwanuka, Noah, Lusiba, John, Atukunda, Angella, Mugume, Raymond, Ssali, Francis, Ddungu, Henry, Katagira, Winceslaus, Sekibira, Rogers, Kityo, Cissy, Kyeyune, Dorothy, Acana, Susan, Aanyu-Tukamuhebwa, Hellen, Kabweru, Wilberforce, Nakwagala, Fred, Bagaya, Bernard Sentalo, Kimuli, Ivan, Nantanda, Rebecca, Buregyeya, Esther, Byarugaba, Baterana, Olaro, Charles, Mwebesa, Henry, Joloba, Moses Lutaakome, Siddharthan, Trishul, Bazeyo, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Respiratory Infection
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354811/
https://www.ncbi.nlm.nih.gov/pubmed/34376401
http://dx.doi.org/10.1136/bmjresp-2021-001017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354811/
https://www.ncbi.nlm.nih.gov/pubmed/34376401
http://dx.doi.org/10.1136/bmjresp-2021-001017

Ejemplares similares